Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holgate, S. T.
Right arrow Articles by Davies, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holgate, S. T.
Right arrow Articles by Davies, D. E.
The Proceedings of the American Thoracic Society 3:440-443 (2006)
© 2006 The American Thoracic Society

The Genetics of Asthma

ADAM33 as an Example of a Susceptibility Gene

Stephen T. Holgate, Youwen Yang, Hans-Michael Haitchi, Rob M. Powell, John W. Holloway, Hajime Yoshisue, Yun Yun Pang, Julie Cakebread and Donna E. Davies

Division of Infection, Inflammation and Repair, School of Medicine, University of Southampton, and Southampton General Hospital, Southampton, United Kingdom

Correspondence and requests for reprints should be addressed to Professor S.T. Holgate, M.D., D.Sci., F.Med.Sci., Infection, Inflammation, and Repair Division, MP810, F Level, South Block, Southampton General Hospital, Southampton SO16 6YD, UK. E-mail: sth{at}soton.ac.uk

ABSTRACT

The ability to identify novel disease genes by positional cloning led to the identification of a disintegrin and metalloprotease (ADAM)33 gene on chromosome 20p13 as a susceptibility gene for asthma. Case-control and family-based association studies have mostly confirmed a link between ADAM33 and asthma. Its restricted expression to mesenchymal cells as well as its association with bronchial hyperresponsiveness and accelerated decline in lung function over time point strongly to its involvement in the structural airway components of asthma, such as remodeling. Extensive alternative splicing, expression during branching morphogensis in the developing fetus, impaired lung function in childhood, the production of a soluble form linked to chronic asthma, and tight epigenetic regulation indicate a level of complexity in the way ADAM33 influences disease phenotype. Its recent association with chronic obstructive pulmonary disease as well as with asthma and lung development points to functions relating to airway wall modeling and remodeling as a general morphogenetic repair gene rather than being restricted to asthma.

Key Words: ADAMs • asthma • biomarkers • hyperresponsiveness




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
J. G. Martin and T. Jo
Genetic Differences in Airway Smooth Muscle Function
Proceedings of the ATS, January 1, 2008; 5(1): 73 - 79.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. C. Moore and S. P. Peters
Update in Asthma 2006
Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 649 - 654.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Thoracic Society.